|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$59,142.45 |
2.89% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$52,080.00 |
2.54% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,750.46 |
2.38% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$45,267.12 |
2.21% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$44,947.21 |
2.19% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$44,619.85 |
2.18% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,577.13 |
2.18% |
| Waters Corporation |
WAT |
941848103 |
120 |
$44,602.80 |
2.18% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$44,212.75 |
2.16% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,265.35 |
2.16% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,644.90 |
2.13% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,503.16 |
2.12% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$42,848.08 |
2.09% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$42,744.28 |
2.09% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$42,489.55 |
2.07% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$41,808.36 |
2.04% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,570.38 |
2.03% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$41,358.18 |
2.02% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,198.08 |
2.01% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,945.04 |
2.00% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$41,054.10 |
2.00% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$41,032.56 |
2.00% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$40,786.71 |
1.99% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$40,727.07 |
1.99% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$40,868.30 |
1.99% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$40,465.84 |
1.98% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$40,617.14 |
1.98% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$40,099.46 |
1.96% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$40,013.55 |
1.95% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$39,795.74 |
1.94% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$39,527.60 |
1.93% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,512.16 |
1.93% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$39,522.92 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,807.27 |
1.89% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,605.25 |
1.88% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$38,539.60 |
1.88% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,580.45 |
1.88% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,034.36 |
1.86% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$38,057.76 |
1.86% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,727.61 |
1.84% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,577.64 |
1.83% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,258.50 |
1.82% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,983.08 |
1.81% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,969.03 |
1.80% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$36,848.29 |
1.80% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,495.53 |
1.78% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$36,539.60 |
1.78% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$34,517.20 |
1.68% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$33,660.00 |
1.64% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$32,706.00 |
1.60% |
| US Dollar |
$USD |
|
2,306 |
$2,306.23 |
0.11% |
| Japanese Yen |
$JPY |
|
77,396 |
$504.41 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
-337 |
($443.75) |
-0.02% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|